natgillin/translations-raw huggingface dataset:
information on the frequency, circumstances and/or quantities in which a new psychoactive substance is encountered, and information on the means and methods of manufacture of the new psychoactive substance;
podatke o pogostosti, okoliščinah in/ali količinah, v katerih se nova psihoaktivna snov pojavlja, ter podatke o sredstvih in načinih proizvodnje nove psihoaktivne snovi;
information on the involvement of organised crime in the manufacture or trafficking of the new psychoactive substance;
podatke o vpletenosti organiziranega kriminala v proizvodnjo ali trgovino z novo psihoaktivno snovjo;
a first indication of the risks associated with the new psychoactive substance, including the health and social risks, and the characteristics of users;
okvirno informacijo o tveganjih v zvezi z novo psihoaktivno snovjo, vključno z zdravstvenimi in socialnimi tveganji, ter o značilnostih uporabnikov;
information on whether or not the new substance is currently under assessment, or has been under assessment, by the UN system;
podatke o tem, ali se nova snov ocenjuje ali ne oziroma ali je že bila predmet ocenjevanja v okviru sistema ZN;
the date of notification on the Reporting Form of the new psychoactive substance to the EMCDDA or to Europol;
datum prijave z obrazcem za poročanje o novi psihoaktivni snovi ECSDZD ali Europolu;
information on whether or not the new psychoactive substance is already subject to control measures at national level in a Member State;
podatke o tem, ali je nova psihoaktivna snov že predmet nadzornih ukrepov na nacionalni ravni v državi članici;
as far as possible, information will be made available on:
kolikor je mogoče, pa se priskrbijo še podatki o:
the chemical precursors that are known to have been used for the manufacture of the substance,
kemičnih predhodnih sestavinah, za katere se ve, da so bile uporabljene za proizvodnjo snovi;
the mode and scope of the established or expected use of the new substance,
načinu in obsegu ugotovljene ali pričakovane rabe nove snovi;
any other use of the new psychoactive substance and the extent of such use, the risks associated with this use of the new psychoactive substance, including the health and social risks.
drugi uporabi nove psihoaktivne snovi in obsegu take uporaba ter tveganju v zvezi s to uporabo nove psihoaktivne snovi, vključno z zdravstvenimi in socialnimi tveganji.
The EMEA shall submit to Europol and the EMCDDA the following information on whether in the European Union or in any Member State:
EAVZ Europolu in ECSDZD posreduje podatke o tem, ali je v Evropski uniji oziroma v kateri koli državi članici:
the new psychoactive substance has obtained a marketing authorisation;
nova psihoaktivna snov pridobila dovoljenje za promet;
the new psychoactive substance is the subject of an application for a marketing authorisation;
za novo psihoaktivno snov vložena vloga za pridobitev dovoljenja za promet;
a marketing authorisation that had been granted in respect of the new psychoactive substance has been suspended.
bilo izdano dovoljenje za promet za novo psihoaktivno snov začasno preklicano.
Where this information relates to marketing authorisations granted by Member States, these Member States shall provide the EMEA with this information if so requested by it.
Če se ti podatki nanašajo na dovoljenja za promet, ki jih izdajo države članice, slednje te podatke posredujejo EAVZ na njeno zahtevo.
Member States shall provide the details referred to under paragraph 2 within six weeks from the date of notification on the Reporting Form as set out in Article 4(1).
Države članice posredujejo podatke iz odstavka 2 v roku šestih tednov od datuma prijave z obrazcem za poročanje, kot je določeno v členu 4(1).
The Joint Report shall be submitted no more than four weeks after the date of receipt of the information from Member States and the EMEA.
Skupno poročilo se predloži najkasneje v roku štirih tednov od datuma prejema podatkov od držav članic in EAVZ.
The Report shall be submitted by Europol or the EMCDDA, as appropriate, in accordance with Article 5(1) and (2).
Poročilo predloži Europol ali ECSDZD, kot je ustrezno, v skladu s členom 5(1) in (2).
Risk assessment
Ocena tveganja
The Council, taking into account the advice of Europol and the EMCDDA, and acting by a majority of its members, may request that the risks, including the health and social risks, caused by the use of, the manufacture of, and traffic in, a new psychoactive substance, the involvement of organised crime and possible consequences of control measures, be assessed in accordance with the procedure set out in paragraphs 2 to 4, provided that at least a quarter of its members or the Commission have informed the Council in writing that they are in favour of such an assessment.
Ob upoštevanju nasvetov Europola in ECSDZD lahko Svet z navadno večino zahteva, da se tveganja, vključno z zdravstvenimi in socialnimi tveganji, ki jih povzroči uporaba, proizvodnja in trgovina z novo psihoaktivno snovjo, vpletenost organiziranega kriminala in možne posledice nadzornih ukrepov ocenijo v skladu s postopkom iz odstavkov 2 do 4, pod pogojem, da predhodno vsaj četrtina njegovih članov ali Komisija Svet pisno obvesti, da odobravajo tako ocenjevanje.
The Member States or the Commission shall inform the Council thereof as soon as possible, but in any case within four weeks of receipt of the Joint Report.
Države članice ali Komisija Svet o tem obvestijo takoj, ko je mogoče, v vsakem primeru pa v roku štirih tednov od prejema skupnega poročila.
The General Secretariat of the Council shall notify this information to the EMCDDA without delay.
Generalni sekretariat Sveta to informacijo nemudoma posreduje ECSDZD.
In order to carry out the assessment, the EMCDDA shall convene a special meeting under the auspices of its Scientific Committee.
Za izvedbo ocene ECSDZD skliče poseben sestanek pod okriljem svojega znanstvenega odbora.
In addition, for the purpose of this meeting the Scientific Committee may be extended by a further five experts at most, to be designated by the Director of the EMCDDA, acting on the advice of the Chairperson of the Scientific Committee, chosen from a panel of experts proposed by Member States and approved every three years by the Management Board of the EMCDDA.
Za potrebe tega sestanka se znanstveni odbor lahko razširi z največ petimi dodatnimi strokovnjaki, ki jih na predlog predsednika znanstvenega odbora imenuje direktor ECSDZD iz skupine strokovnjakov, ki jih predlagajo države članice in vsaka tri leta potrdi upravni odbor ECSDZD.
Such experts will be from scientific fields that are not represented, or not sufficiently represented, in the Scientific Committee, but whose contribution is necessary for the balanced and adequate assessment of the possible risks, including health and social risks.
Ti strokovnjaki so s tistih znanstvenih področij, ki niso zastopana ali ki niso dovolj zastopana v znanstvenem odboru, njihov prispevek pa je potreben za uravnoteženo in ustrezno ocenjevanje možnih tveganj, vključno z zdravstvenimi in socialnimi tveganji.
Furthermore, the Commission, Europol and the EMEA shall each be invited to send a maximum of two experts.
Prav tako se Komisijo, Europol in EAVZ pozove, da pošljejo vsak največ po dva strokovnjaka.
The risk assessment shall be carried out on the basis of information to be provided to the scientific Committee by the Member States, the EMCDDA, Europol, the EMEA, taking into account all factors which, according to the 1961 United Nations Single Convention on Narcotic Drugs or the 1971 United Nations Convention on Psychotropic Substances, would warrant the placing of a substance under international control.
Ocena tveganja se izvede na podlagi podatkov, ki jih države članice, ECSDZD, Europol in EAVZ posredujejo znanstvenemu odboru, ob upoštevanju vseh dejavnikov, ki v skladu z Enotno konvencijo Združenih narodov o mamilih iz leta 1961 ali Konvencijo Združenih narodov o psihotropnih snoveh iz leta 1971 opravičujejo uvedbo mednarodnega nadzora nad snovjo.
On completion of the risk assessment, a report (hereinafter the ‘Risk Assessment Report’) shall be drawn up by the Scientific Committee.
Po izvedeni oceni tveganja znanstveni odbor pripravi poročilo (v nadaljnjem besedilu „poročilo o oceni tveganja“).
The Risk Assessment Report shall consist of an analysis of the scientific and law enforcement information available, and shall reflect all opinions held by the members of the Committee.
Poročilo o oceni tveganja vsebuje analizo dostopnih znanstvenih podatkov in podatkov s področja kazenskega pregona ter odraža vsa mnenja članov odbora.
The Risk Assessment Report shall be submitted to the Commission and Council by the chairperson of the Committee, on its behalf, within a period of twelve weeks from the date of the notification by the General Secretariat of the Council to the EMCDDA referred to in paragraph 1.
Poročilo o oceni tveganja predsednik znanstvenega odbora v svojem imenu predloži Komisiji in Svetu v roku dvanajstih tednov od datuma, ko generalni sekretariat Sveta ECSDZD pošlje obvestilo iz odstavka 1.
The Risk Assessment Report shall include:
Poročilo o oceni tveganja vsebuje:
the physical and chemical description of the new psychoactive substance and its mechanisms of action, including its medical value;
fizikalni in kemijski opis nove psihoaktivne snovi ter mehanizme njenega delovanja, vključno z njeno zdravstveno vrednostjo;
the health risks associated with the new psychoactive substance;
zdravstvena tveganja v zvezi z novo psihoaktivno snovjo;
the social risks associated with the new psychoactive substance;
socialna tveganja v zvezi z novo psihoaktivno snovjo;
information on the level of involvement of organised crime and information on seizures and/or detections by the authorities, and the manufacture of the new psychoactive substance;
podatke o ravni vpletenosti organiziranega kriminala ter podatke o uradnih zasegih in/ali odkritjih in o proizvodnji nove psihoaktivne snovi;
information on any assessment of the new psychoactive substance in the United Nations system;
podatke o morebitni oceni nove psihoaktivne snovi v sistemu Združenih narodov;
where appropriate, a description of the control measures that are applicable to the new psychoactive substance in the Member States;
če je ustrezno, opis nadzornih ukrepov, ki se uporabljajo za novo psihoaktivno snov v državah članicah;
options for control and the possible consequences of the control measures, and
različne možnosti nadzora in možne posledice nadzornih ukrepov ter
the chemical precursors that are used for the manufacture of the substance.
kemične predhodne sestavine, ki se uporabljajo za proizvodnjo snovi.
Circumstances where no risk assessment is carried out
Okoliščine, v katerih se ocena tveganja ne izvede
No risk assessment shall be carried out in the absence of a Europol/EMCDDA Joint Report.
Ocena tveganja se ne izvede v primeru, če Europol/ECSDZD ne pripravita skupnega poročila.
Nor shall a risk assessment be carried out where the new psychoactive substance concerned is at an advanced stage of assessment within the United Nations system, namely once the WHO expert committee on drug dependence has published its critical review together with a written recommendation, except where there is significant new information that is relevant in the framework of this Decision.
Ocena tveganja se ne izvede tudi, ko je zadevna psihoaktivna snov v zaključnih fazah ocenjevanja v okviru sistema Združenih narodov, tj. ko je strokovni odbor za odvisnost od drog že objavil svoje poročilo s pisnim priporočilom, razen če niso na razpolago pomembni novi podatki, ki so relevantni v smislu tega sklepa.
Where the new psychoactive substance has been assessed within the United Nations system, but it has been decided not to schedule the new psychoactive substance under the 1961 Single Convention on Narcotic Drugs or the 1971 Convention on Psychotropic Substances, a risk assessment shall be carried out only if there is significant new information that is relevant in the framework of this Decision.
Če je bila nova psihoaktivna snov ocenjena v okviru sistema Združenih narodov in je bilo odločeno, da se nova psihoaktivna snov ne uvrsti na seznam Enotne konvencije o mamilih iz leta 1961 ali Konvencije o psihotropnih snoveh iz leta 1971, se ocena tveganja izvede samo, če so na razpolago pomembni novi podatki, ki so relevantni v smislu tega sklepa.
No risk assessment shall be carried out on a new psychoactive substance if:
Ocena tveganja se ne izvede, če:
the new psychoactive substance is used to manufacture a medicinal product which has been granted a marketing authorisation; or,
se nova psihoaktivna snov uporablja za proizvodnjo zdravila, ki ima dovoljenje za promet; ali
the new psychoactive substance is used to manufacture a medicinal product for which an application has been made for a marketing authorisation or,
se nova psihoaktivna snov uporablja za proizvodnjo zdravila, za katerega je vložena vloga za pridobitev dovoljenje za promet; ali
the new psychoactive substance is used to manufacture a medicinal product for which a marketing authorisation has been suspended by a competent authority.
se nova psihoaktivna snov uporablja za proizvodnjo zdravila, ki ima dovoljenje za promet, ki ga je pristojni organ začasno preklical.
Where the new psychoactive substance falls into one of the categories listed under the first subparagraph, the Commission, on the basis of data collected by EMCDDA and Europol, shall assess with the EMEA the need for further action, in close cooperation with the EMCDDA and in accordance with the mandate and procedures of the EMEA.
Če nova psihoaktivna snov sodi v eno od kategorij, naštetih v prvem pododstavku, Komisija na podlagi podatkov, ki jih zbereta ECSDZD in Europol, skupaj z EAVZ oceni potrebo po nadaljnjem ukrepanju v tesnem sodelovanju z ECSDZD ter v skladu s pooblastili in postopki EAVZ.
The Commission shall report to the Council on the outcome.
Komisija o rezultatih poroča Svetu.
Procedure for bringing specific new psychoactive substances under control
Postopek uvedbe nadzora nad določeno novo psihoaktivno snovjo
Within six weeks from the date on which it received the Risk Assessment Report, the Commission shall present to the Council an initiative to have the new psychoactive substance subjected to control measures.
V roku šestih tednov od prejema poročila o oceni tveganja Komisija Svetu predloži pobudo, da se za novo psihoaktivno snov uvedejo nadzorni ukrepi.
If the Commission deems it is not necessary to present an initiative on submitting the new psychoactive substance to control measures, within six weeks from the date on which it received the Risk Assessment Report, the Commission shall present a report to the Council explaining its views.
Če Komisija meni, da ni potrebno, da v roku šestih tednov od datuma prejema poročila o oceni tveganja predloži pobudo, da se za novo psihoaktivno snov uvedejo nadzorni ukrepi, Svetu predloži poročilo, v katerem pojasni svoja stališča.
Should the Commission deem it not necessary to present an initiative on submitting the new psychoactive substance to control measures, such an initiative may be presented to the Council by one or more Member States, preferably not later than six weeks from the date on which the Commission presented its report to the Council.
V primeru, ko Komisija meni, da ni potrebno, da predloži pobudo, da se za novo psihoaktivno snov uvedejo nadzorni ukrepi, lahko tako pobudo Svetu predloži ena ali več držav članic, po možnosti najkasneje v roku šestih tednov od datuma, ko je Komisija Svetu predložila svoje poročilo.
The Council shall decide, by qualified majority and acting on an initiative presented pursuant to paragraph 1 or 2, on the basis of Article 34(2) (c) of the Treaty, whether to submit the new psychoactive substance to control measures.
Svet o na podlagi pobude, predložene v skladu z odstavkom 1 ali 2, na podlagi člena 34(2)(c) Pogodbe s kvalificirano večino odloči, ali se za novo psihoaktivno snov uvedejo nadzorni ukrepi.
Control measures taken by Member States
Nadzorni ukrepi držav članic
If the Council decides to submit a new psychoactive substance to control measures, Member States shall endeavour to take, as soon as possible, but no later than one year from the date of that decision, the necessary measures in accordance with their national law to submit:
Če Svet odloči, da se za novo psihoaktivno snov uvedejo nadzorni ukrepi, si morajo države članice prizadevati, da v najkrajšem možnem času, najkasneje pa v roku enega leta od datuma te odločitve, ukrenejo vse potrebno, da v skladu s svojim nacionalnim pravom uvedejo:
the new psychotropic drug to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances;
za novo psihotropno drogo nadzorne ukrepe in kazenske sankcije, kot jih določa njihova zakonodaja na podlagi obveznosti iz Konvencije Združenih narodov o psihotropnih snoveh iz leta 1971;
the new narcotic drug to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1961 United Nations Single Convention on Narcotic Drugs.
za novo narkotično drogo nadzorne ukrepe in kazenske sankcije, kot jih določa njihova zakonodaja na podlagi obveznosti iz Enotne konvencije Združenih narodov o mamilih iz leta 1961.
Nothing in this Decision shall prevent a Member State from maintaining or introducing on its territory any national control measure it deems appropriate once a new psychoactive substance has been identified by a Member State.
Nič v tem sklepu ne preprečuje državam članicam, da potem, ko je bila v državi članici identificirana nova psihoaktivna snov, na svojem ozemlju ohranijo ali uvedejo kakršen koli nacionalni nadzorni ukrep, za katerega menijo, da je potreben.
Annual report
Letno poročilo
The EMCDDA and Europol shall report annually to the European Parliament, the Council and the Commission on the implementation of this Decision.
ECSDZD in Europol letno poročata Evropskemu parlamentu, Svetu in Komisiji o izvajanju tega sklepa.
The report will take into account all aspects required for an assessment of the efficacy and achievements of the system created by this Decision.
V poročilu se upoštevajo vsi vidiki, potrebni za oceno učinkovitosti in rezultatov sistema, ki ga vzpostavlja ta sklep.
The Report shall, in particular, include experience relating to coordination between the system set out in this Decision and the pharmacovigilance system.
Poročilo še zlasti vsebuje izkušnje v zvezi z usklajevanjem med sistemom, ki ga vzpostavlja ta sklep, in sistemom farmakovigilance.
Pharmacovigilance system
Sistem farmakovigilance
Member States and the EMEA shall ensure an appropriate exchange of information between the mechanism set up by means of this Decision and the pharmacovigilance systems as defined and established under Title VII of Directive 2001/82/EC and Title IX of Directive 2001/83/EC.
Države članice in EAVZ zagotovijo ustrezno izmenjavo podatkov med mehanizmi, vzpostavljenimi s tem sklepom, in sistemoma farmakovigilance, kot sta opredeljena in vzpostavljena v Naslovu VII Direktive 2001/82/ES in naslovu IX Direktive 2001/83/ES.
The Joint Action on New Synthetic Drugs of 16 June 1997 is hereby repealed.
Skupni ukrep o novih sintetičnih drogah z dne 16. junija 1997 se razveljavi.
Decisions taken by the Council based on Article 5 of that Joint Action shall continue to be legally valid.
Sklepi Sveta, sprejeti na podlagi člena 5 tega skupnega ukrepa, ostajajo veljavni.
Publication and taking effect
Objava in začetek učinkovanja
This Decision shall take effect on the day following that of its publication in the Official Journal of the European Union.
Ta sklep začne učinkovati na dan po objavi v Uradnem listu Evropske unije.
Opinion delivered on 13 January 2004 (not yet published in the Official Journal).
Mnenje podano dne 13. januarja 2004 (še ni objavljeno v Uradnem listu).
OJ L 311, 28.11.2001, p. 67.
UL L 311, 28.11.2001, str. 67.
OJ L 357, 20.12.1990, p. 1.
UL L 357, 20.12.1990, str. 1.
Regulation as last amended by Commission Regulation (EC) No 1232/2002 (OJ L 180, 10.7.2002, p. 5).
Uredba, kakor je bila nazadnje spremenjena z Uredbo Komisije (ES) št. 1232/2002 (UL L 180, 10.7.2002, str. 5).
Member States shall report the measures taken to both the Council and the Commission as soon as possible after the relevant decision has been taken. Thereafter this information shall be communicated to the EMCDDA, Europol, the EMEA, and the European Parliament.
Čimprej po sprejemu ustrezne odločitve države članice o sprejetih ukrepih poročajo tako Svetu kot Komisiji; ti podatki se nato sporočijo ECSDZD, Europolu, EAVZ in Evropskemu parlamentu.
Corrigendum to Commission Implementing Decision 2011/878/EU of 20 December 2011 confirming the provisional calculation of average specific CO2 emissions and specific emissions targets for manufacturers of passenger cars for the calendar year 2010 pursuant to Regulation (EC) No 443/2009 of the European Parliament and of the Council
Popravek Izvedbenega sklepa Komisije 2011/878/EU z dne 20. decembra 2011 o potrditvi začasnega izračuna povprečnih specifičnih emisij CO2 in ciljev specifičnih emisij za proizvajalce osebnih avtomobilov za koledarsko leto 2010 v skladu z Uredbo (ES) št. 443/2009 Evropskega parlamenta in Sveta
(Official Journal of the European Union L 343 of 23 December 2011)
(Uradni list Evropske unije L 343 z dne 23. decembra 2011)
Following a clerical error in column B of Table 1 of the Annex, the entry ‘D’ for Jaguar Cars Ltd, Land Rover and Tata Motors Limited shall be replaced by ‘ND’.
Zaradi napake v stolpcu B Preglednice 1 v Prilogi se vnos „D“ za Jaguar Cars Ltd, Land Rover in Tata Motors Limited nadomesti z „ND“.
Following a clerical error in columns G, H and I of Table 2 of the Annex, the entries for Ford-Werke GmbH and Daimler AG in columns G and H and all entries in column I shall be replaced by the following:
Zaradi napake v stolpcih G, H in I Preglednice 2 v Prilogi se vnosi za Ford-Werke GMBH in Daimler AG v stolpcih G in H ter vsi vnosi v stolpcu I nadomestijo z naslednjim:
Pool Name
Ime združenja
Pool
Združenje
Distance to target adjusted
Prilagojeno odstopanje od cilja
Average mass
Povprečna masa
Average CO2 (100 %)
Povprečne emisije CO2 (100 %)
‘FORD-WERKE GMBH
„FORD-WERKE GMBH
concerning the measures necessary as regards an obstacle to trade constituted by trade practices maintained by Brazil affecting trade in retreaded tyres
o potrebnih ukrepih v zvezi s trgovinsko oviro, ki jo povzroča trgovinska praksa Brazilije in ki vpliva na trgovino s protektiranimi gumami
(notified under document number C(2005) 1302)
(notificirano pod dokumentarno številko K(2005) 1302)
Having regard to Council Regulation (EC) No 3286/94 of 22 December 1994 [1] laying down Community procedures in the field of the common commercial policy in order to ensure the exercise of the Community’s rights under international trade rules, in particular those established under the auspices of the World Trade Organisation (WTO), and in particular Articles 12(1) and 13(2) thereof,
ob upoštevanju Uredbe Sveta (ES) št. 3286/94 z dne 22. decembra 1994 o določitvi postopkov Skupnosti na področju skupne trgovinske politike za zagotovitev izvrševanja pravic Skupnosti po mednarodnih pravilih trgovanja, zlasti tistih, ki so dogovorjena v okviru Svetovne trgovinske organizacije [1], in zlasti členov 12(1) in 13(2) Uredbe,
On 5 November 2003, the Commission received a complaint pursuant to Article 4 of Regulation (EC) No 3286/94 (the Trade Barriers Regulation).
Komisija je 5. novembra 2003 prejela pritožbo v skladu s členom 4 Uredbe (ES) št. 3286/94 („Uredba o trgovinskih ovirah“).
The complaint was lodged by the Bureau international permanent des associations de vendeurs et rechapeurs de pneumatiques (Bipaver).
Pritožbo je vložil Bureau International Permanent des Associations de Vendeurs et Rechapeurs de Pneumatiques („BIPAVER“).
The complaint concerned certain alleged Brazilian trade practices that prevented the importation into Brazil of retreaded tyres [2].
Pritožba je zadevala nekatere domnevne brazilske trgovinske prakse, ki so preprečevale uvoz protektiranih gum [2] v Brazilijo.